he scientific program aims to promote an excellent and critical review of relevant diagnostic and therapeutic developments in the areas of malignant blood disorders, including leukemia, myeloma and congenital anomalies syndrome.
From 2018/03/02 To 2018/03/03
From : 04:00:00 pm To 09:00:00 pm
Last Modified Date: 15/07/2021 - 12:22 AM Saudi Arabia Time